Primary gastric lymphoma, epidemiology, clinical diagnosis, and treatment

LM Juárez-Salcedo, L Sokol, JC Chavez… - Cancer …, 2018 - journals.sagepub.com
Primary gastric lymphoma (PGL) is the most common extranodal non-Hodgkin lymphoma
and represents a wide spectrum of disease, ranging from indolent low-grade marginal zone …

[HTML][HTML] MALT lymphoma: epidemiology, clinical diagnosis and treatment

PV Filip, D Cuciureanu, LS Diaconu… - Journal of medicine …, 2018 - ncbi.nlm.nih.gov
Primary gastric lymphoma (PGL) represents a rare pathology, which can be easily
misdiagnosed because of unspecific symptoms of the digestive tract. Histologically, PGL can …

[PDF][PDF] Gastrointestinal non-Hodgkin lymphomas

M Olszewska-Szopa, T Wróbel - Adv Clin Exp Med, 2019 - dbc.wroc.pl
Although gastrointestinal (GI) tract is the most common extranodal site involved in non-
Hodgkin lymphoma (NHL), primary gastrointestinal NHL (gNHL) is a rare problem which …

[HTML][HTML] Diffuse gastric cancer: a summary of analogous contributing factors for its molecular pathogenicity

S Ansari, B Gantuya, VP Tuan, Y Yamaoka - International journal of …, 2018 - mdpi.com
Gastric cancer is the third leading cause of cancer-related deaths and ranks as the fifth most
common cancer worldwide. Incidence and mortality differ depending on the geographical …

[HTML][HTML] Clinical features and outcomes of diffuse large B-cell lymphoma based on nodal or extranodal primary sites of origin: Analysis of 1,085 WHO classified cases …

Y Shi, Y Han, J Yang, P Liu, X He, C Zhang… - Chinese journal of …, 2019 - ncbi.nlm.nih.gov
Objective To explore the clinicobiologic features and outcomes of diffuse large B-cell
lymphoma (DLBCL) patients in China according to the primary site. Methods A total of 1,085 …

JAK/STAT of all trades: linking inflammation with cancer development, tumor progression and therapy resistance

HE Sabaawy, BM Ryan, H Khiabanian… - …, 2021 - academic.oup.com
Inflammation is at the forefront of carcinogenesis, tumor progression and resistance to
therapy. The Janus kinase (JAK)/signal transducer and activator of transcription (STAT) …

[HTML][HTML] Helicobacter pylori infection and gastric cancer biology: tempering a double-edged sword

AFA Mentis, M Boziki, N Grigoriadis… - Cellular and Molecular …, 2019 - Springer
Helicobacter pylori (H. pylori) infection affects an estimated 4.4 billion people globally.
Moreover, H. pylori presents the most significant risk factor for gastric cancer and low-grade …

Primary gastrointestinal non-Hodgkin's lymphoma of the small and large intestines: a systematic review

AL Lightner, E Shannon, MM Gibbons… - Journal of Gastrointestinal …, 2016 - Elsevier
Abstract Background Primary gastrointestinal non-Hodgkin's lymphoma (PGINHL) of small
and large intestines is a group of heterogeneous, rare malignancies. Optimal treatment …

[HTML][HTML] Inflammatory bowel disease and risk of adenocarcinoma and neuroendocrine tumors in the small bowel

J Yu, E Refsum, V Perrin, LM Helsingen, P Wieszczy… - Annals of …, 2022 - Elsevier
Background Uncertainty prevails about the magnitude of excess risk of small bowel cancer
in patients with inflammatory bowel disease (IBD). Patients and methods To quantify the risk …

[HTML][HTML] Involvement of non-Helicobacter pylori helicobacter infections in Helicobacter pylori-negative gastric MALT lymphoma pathogenesis and efficacy of …

H Takigawa, R Yuge, S Masaki, R Otani, H Kadota… - Gastric Cancer, 2021 - Springer
Background Eradication therapy is known to be effective against Helicobacter pylori-positive
gastric MALT lymphoma but predicting the efficacy of eradication therapy against …